HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.

Abstract
Chronic granulomatous disease, a disorder of host defense, is characterized by an impairment in the killing of microbes that results from a defect in the production of superoxide anion by phagocytes. We examined the efficacy of interferon gamma, a physiologic activator of phagocytic-cell function, in the treatment of the disease. Two subcutaneous injections of recombinant interferon gamma (0.1 mg per square meter of body-surface area per dose) were administered on consecutive days to four patients with the X-linked form of the disease. Treatment resulted in 5- to 10-fold increases in superoxide production by granulocytes and monocytes; the improvement was sustained for more than two weeks. Granulocyte bactericidal activity rose proportionally. In the two most responsive patients, both phagocytic functions reached the normal range of activity. In association with these functional changes, we observed an increase in cellular contents of phagocyte cytochrome b (a critical component of the superoxide-producing oxidase) and immunoreactive cytochrome b heavy chain (the product of the gene that is defective in X-linked chronic granulomatous disease). Levels of cytochrome b detected by spectrophotometry rose from near zero to 10 to 50 percent of normal values. This study demonstrates partial correction of the cellular defects in chronic granulomatous disease by interferon gamma and provides a basis for clinical trials of the agent.
AuthorsR A Ezekowitz, M C Dinauer, H S Jaffe, S H Orkin, P E Newburger
JournalThe New England journal of medicine (N Engl J Med) Vol. 319 Issue 3 Pg. 146-51 (Jul 21 1988) ISSN: 0028-4793 [Print] United States
PMID2838754 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cytochrome b Group
  • Recombinant Proteins
  • Superoxides
  • Interferon-gamma
Topics
  • Adult
  • Blood Bactericidal Activity
  • Cytochrome b Group (analysis)
  • Genetic Linkage
  • Granulomatous Disease, Chronic (genetics, immunology, therapy)
  • Humans
  • Injections, Subcutaneous
  • Interferon-gamma (administration & dosage, therapeutic use)
  • Male
  • Phagocytes (enzymology)
  • Phagocytosis
  • Recombinant Proteins (administration & dosage, therapeutic use)
  • Superoxides (metabolism)
  • X Chromosome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: